PURPOSE: This study presents the results of peripheral @entity653 injections in @entity1 with @entity4254 . @entity1 AND METHODS: The @entity1 who either failed to respond to drug therapy or developed serious side effects were treated by means of @entity653 injections. Medical records and questionnaires on 157 @entity1 treated between 1983 and 1996 were evaluated. The minimum follow-up period for each @entity1 was 4 years. RESULTS: The study population included 65 males and 92 females. The right side (112 @entity1 , 71%) was affected more commonly than the left. The most common distribution was in the second and the third trigeminal divisions. The initial success rate was 98%. @entity158 recurred in 60 @entity1 and was most frequently recorded between 25 and 36 months postinjection (28 of the 60 recurrences). These @entity1 were successfully reinjected. At the end of 4 years, complete or almost complete @entity158 relief was obtained in 154 @entity1 . CONCLUSIONS: Peripheral @entity653 injection is a minimally invasive and useful technique to manage @entity4254 , with a high success rate and low incidence of morbidity.

Peripheral XXXX injections in the treatment of @entity4254 : retrospective analysis of 157 cases.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity4254 :: ('MESH:D014277', 'Disease') :: ['idiopathic trigeminal neuralgia', 'trigeminal neuralgia'] @entity158 :: ('MESH:D010146', 'Disease') :: ['Pain', 'pain'] @entity653 :: ('MESH:D005990', 'Chemical') :: ['glycerol']
@entity653 :: (MESH:D005990,Chemical) :: ['glycerol']
